investors.tiongseng.com.sg
Investor Relations | Tiong Seng Holdings
Awards & Accreditation. Building Construction & Civil Engineering. Established since 1959, we are one of the leading building construction and civil engineering contractors in Singapore. We are principally engaged in building construction and civil engineering in Singapore, as well as property development in the PRC. Established track record of more than 50 years. Experienced and dedicated management team. Strong focus on cost efficiencies, quality and reliability. Aug 14, 2015. Aug 14, 2015. Jul 1, 2015.
investors.tiptreefinancial.com
Tiptree | Investor Resources
Tiptree Financial Inc. Q2 2015 Earnings Conference Call. Friday, August 14th, 2015.
investors.tognum.com
Tognum - Tognum at a glance
Tognum at a glance. How to find us. MTU / MTU Onsite Energy Sales and Service Locator. Tognum at a glance. Tognum at a glance. Tognum AG: Release according to Article 30e of the WpHG [the German Securities Trading Act] with the objecti. Tognum AG: Notification published in accordance with Sec. 15 WpHG. 2012 financial year: Tognum in line with forecast. Tognum AG: Announcement according to Articles 37v, 37w, 37x et seqq. of the WpHG [the German Securities Act]. Annual Report 2012 (PDF, 4,3 MB).
investors.tognum.de
Tognum - Tognum im Überblick
MTU / MTU Onsite Energy Sales and Service Locator. Tognum AG: Veröffentlichung gemäß 30e WpHG mit dem Ziel der europaweiten Verbreitung. Tognum AG: Ad-hoc-Meldung gemäß 15 WpHG. Geschäftsjahr 2012: Tognum erfüllt Prognose. Tognum AG: Bekanntmachung gemäß 37v, 37w, 37x ff. WpHG mit dem Ziel der europaweiten Verbreitung. Tognum AG: Veröffentlichung gemäß 26 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung. PDF, 4,3 MB). Außerordentliche Hauptversammlung am 15.11.2012. Tel: 49 (0) 7541 90-3318.
investors.tokaipharma.com
Overview - Investors & Media - Tokai Pharmaceuticals
Tokai Pharmaceuticals is focused on developing and delivering innovative therapies that provide hope and healing for patients living with cancer. Tokai also has an ongoing program to identify and develop novel compounds designed to disrupt androgen receptor signaling through enhanced androgen receptor degradation. Tokai Pharmaceuticals Reports Second Quarter 2015 Results. ARMOR3-SV Represents the First Precision Medicine-Based Pivotal Clinical Trial in Prostate Cancer; Topline Data Expected by the End of...
investors.tokaipharmaceuticals.com
Tokai Nasdaq | Investors & Media | Overview
160; 0.02. Data provided by Nasdaq. Minimum 15 minutes delayed. Tokai Pharmaceuticals and Otic Pharma Enter into Share Purchase Agreement. Tokai Pharmaceuticals Announces Review of Strategic Alternatives. Tokai Pharmaceuticals Announces Reduction in Force. BOSTON- (BUSINESS WIRE)- Jul. 29, 2016- Tokai Pharmaceuticals Inc. (NASDAQ: TKAI), a biopharmaceutical company focused on developing and commercializing innovative therapies for prostate cancer and other hormonally driven diseases, today announ...Tokai...
investors.tornos.com
Welcome to the investors' area | Tornos Investors
Control and warding-off mechanisms. Information and disclosure policy. Participation rights of shareholders. Control and warding-off mechanisms. Information and disclosure policy. Participation rights of shareholders. Tornos Group is one of the global leaders for the development, production and distribution of Swiss-type automatic lathes and multi-spindle machines. The company’s history dates back to 1880 and marked the beginning of Swiss-type lathe technology. Subscribe to Tornos news.
investors.totalproduce.com
Investors – Total Produce plc
Irish Stock Exchange (Currency EUR). London Stock Exchange (Currency GBP). Total Produce plc raises 2016. VIEW ALL INVESTOR NEWS. Latest Results and Presentations. 2016 Interim Results Presentation. VIEW ALL RESULTS AND PRESENTATIONS. A Global Business with Local Knowledge. Total Produce PLC 29. North Anne Street, Dublin 7. D07 PH36, Ireland. 353 (0) 1 887 2600.
investors.towerinternational.com
Tower International Inc - Investor Relations - Corporate Overview
Tower International, Inc. is one of the largest independent global suppliers of automotive metal structural components and assemblies. We serve virtually every major automotive vehicle manufacturer, providing a broad range of metal structures from stampings to complex body and frame assemblies. Tower's global reach enables us to serve customers close to their assembly plants around the world. With corporate headquarters in Livonia, Michigan, U.S., our 8,700 colleagues support our c. 160; 0.51. Replicatio...
investors.trademe.co.nz
Investor Relations – Trade Me Group Ltd
Skip to main content. Trade Me's acquisition of Motorcentral declined by Commerce Commission. 09 March, 2018. In July 2017, Trade Me advised it had entered into a conditional agreement to purchase Limelight Software Limited, trading as Motorcentral (motorcentral.co.nz), a cloud-based dealer management pla. Continue. TME Interim Result: Record revenue underpinned by Classifieds strength. 28 February, 2018. Webcast info: Trade Me FY18 interim results. 14 February, 2018. Data as at 3/30/2018 5:36:30 PM.
investors.trendlines.com
Investors – Trendlines
Skip to main content. Trendlines invents, discovers, invests in, and incubates innovation-based medical and agricultural technologies. We took two companies public and exited six companies. Director, Investor Relations and Corporate Communications. Romil Singh / Reyna Mei. Financial PR Pte Ltd. December 2016 Monthly Update. PrimePartners Corporate Finance Holdings Invests in Trendlines Medical. Financial Reports and Presentations. Investor Presentation January 2017. Q3 2016 Financial Results (Unaudited).
SOCIAL ENGAGEMENT